Hillman Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-66,707
Closed -$5.75M 53
2022
Q3
$5.75M Sell
66,707
-31,407
-32% -$2.8M 2.38% 28
2022
Q2
$8.95M Sell
98,114
-1,385
-1% -$123K 3.25% 8
2022
Q1
$8.16M Buy
99,499
+803
+0.8% +$63.3K 2.59% 22
2021
Q4
$7.56M Sell
98,696
-1,041
-1% -$82.9K 2.6% 21
2021
Q3
$7.49M Buy
99,737
+4,180
+4% +$318K 2.63% 23
2021
Q2
$7.43M Buy
95,557
+24,316
+34% +$1.81M 2.83% 19
2021
Q1
$5.24M Buy
71,241
+9,534
+15% +$703K 2.3% 29
2020
Q4
$4.82M Buy
61,707
+21,394
+53% +$1.64M 2.6% 23
2020
Q3
$3.19M Sell
40,313
-54
-0.1% -$4.23K 2.25% 29
2020
Q2
$2.98M Sell
40,367
-4
-0% -$301 2.17% 28
2020
Q1
$2.96M Buy
40,371
+3,210
+9% +$252K 2.84% 16
2019
Q4
$3.23M Buy
+37,161
New +$3.05M 2.29% 23
2013
Q4
$891K Hold
18,662
1.33% 28
2013
Q3
$812K Hold
18,662
1.24% 26
2013
Q2
$862K Buy
+18,662
New +$834K 1.2% 34

Other funds holding MRK

Hillman Capital Management's MRK Position: Q4 2022 in Review

Hillman Capital Management sold out of Merck (MRK) in Q4 2022, closing a stake of 66,707 shares — an estimated $5.75M sold.

Hillman Capital Management first reported a position in MRK in Q2 2013 and held it in 15 quarters. The position peaked at $8.95M in Q2 2022. 3,236 funds tracked by Wall St. Rank hold MRK as of Q4 2022.

  • Hillman Capital Management reported no remaining Merck position as of Q4 2022 after selling out during the quarter.
  • Hillman Capital Management sold 66,707 Merck shares in Q4 2022, an estimated $5.75M.
  • Hillman Capital Management first reported a position in Merck in Q2 2013 and held it in 15 quarters.
  • Hillman Capital Management's Merck position peaked at $8.95M in Q2 2022.
  • 3,236 funds tracked by Wall St. Rank held Merck as of Q4 2022.

Based on Hillman Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.